A significant reduction in the levels of secreted MMP-9, compared to control levels, was observed in neuroblastoma cell lines treated either with AMD 3100 or with anti-47 kDa CXCR4 neutralizing antibody (Fig. 5b). This evidence concerns the gene MMP9 and neuroblastoma.